Atlas Trials

OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study

Clinical trial NCT01920945 · TERMINATED

Trial details

NCT number
NCT01920945
Sponsor
St. Luke's-Roosevelt Hospital Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
New Daily Persistent Headache
Start date
2014-09-01
Primary completion
2016-10-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.